Tuesday, 29 April 2025
  
Login

Australia's most trusted
source of pharma news

Tuesday, 29 April 2025
News

Yes... but with a price reduction

Posted 28 April 2025 AM

The PBAC was generous at its March meeting, recommending every change to existing listing that crossed its desk.

But in many cases the Committee voiced concerns about the economic model used, giving a positive recommendation accompanied by a price reduction or risk sharing agreement.

To see the whole article, please login

Popular

Yes... but with a price reduction
Approval tainted by PBAC 'No'
Finally, a PBS listing after 1514 days
TGA hunting Committee experts
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home